These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23147755)

  • 41. Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasis.
    Elewski B; Leonardi C; Gottlieb AB; Strober BE; Simiens MA; Dunn M; Jahreis A
    Br J Dermatol; 2007 Jan; 156(1):138-42. PubMed ID: 17199580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Psoriasis vulgaris in a hepatitis B virus carrier successfully treated with secukinumab and entecavir combination therapy.
    Yanagihara S; Sugita K; Yoshida Y; Tsuruta D; Yamamoto O
    Eur J Dermatol; 2017 Apr; 27(2):185-186. PubMed ID: 27965188
    [No Abstract]   [Full Text] [Related]  

  • 43. Novel combination regimens: biologics and acitretin for the treatment of psoriasis-- a case series.
    Conley J; Nanton J; Dhawan S; Pearce DJ; Feldman SR
    J Dermatolog Treat; 2006; 17(2):86-9. PubMed ID: 16766332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.
    Krueger GG; Langley RG; Finlay AY; Griffiths CE; Woolley JM; Lalla D; Jahreis A
    Br J Dermatol; 2005 Dec; 153(6):1192-9. PubMed ID: 16307657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Etanercept therapy in patients with autoimmunity and hepatitis C.
    Khanna M; Shirodkar MA; Gottlieb AB
    J Dermatolog Treat; 2003 Dec; 14(4):229-32. PubMed ID: 14660270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term safety and efficacy of etanercept in patients with psoriasis: an open-label study.
    Leonardi C; Strober B; Gottlieb AB; Elewski BE; Ortonne JP; van de Kerkhof P; Chiou CF; Dunn M; Jahreis A
    J Drugs Dermatol; 2010 Aug; 9(8):928-37. PubMed ID: 20684143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suspected rapid-onset neutropenia following etanercept use: disproved following rechallenge and lessons to be learned.
    Sachdev A; Shwayder T
    Int J Dermatol; 2013 Oct; 52(10):1287-8. PubMed ID: 22417135
    [No Abstract]   [Full Text] [Related]  

  • 48. Etanercept therapy in a hepatitis B virus (HBV)-positive psoriatic patient developing a monoclonal gammopathy of undetermined significance.
    Prignano F; Ricceri F; Pescitelli L; Bonciani D; Lotti T
    Int J Dermatol; 2011 Aug; 50(8):999-1001. PubMed ID: 21781077
    [No Abstract]   [Full Text] [Related]  

  • 49. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
    Kircik LH
    J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of etanercept in patients with psoriasis and hepatitis C.
    Ventura F; Gomes J; Duarte Mda L; Fernandes JC; Brito C
    Eur J Dermatol; 2010; 20(6):808-9. PubMed ID: 20923749
    [No Abstract]   [Full Text] [Related]  

  • 51. Successful treatment of recalcitrant palmoplantar psoriasis with etanercept.
    Weinberg JM
    Cutis; 2003 Nov; 72(5):396-8. PubMed ID: 14655781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks.
    Gambichler T; Tigges C; Scola N; Weber J; Skrygan M; Bechara FG; Altmeyer P; Kreuter A
    Br J Dermatol; 2011 Jun; 164(6):1383-6. PubMed ID: 21466532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [New advances in the treatment of chronic hepatitis B: position of entecavir].
    Olaso V
    Rev Esp Quimioter; 2007 Sep; 20(3):259-60. PubMed ID: 18080023
    [No Abstract]   [Full Text] [Related]  

  • 54. OBSERVE-5 interim analysis: an observational postmarketing safety registry of etanercept for the treatment of psoriasis.
    Kimball AB; Pariser D; Yamauchi PS; Menter A; Teller CF; Shi Y; Yong M; Creamer K; Hooper M; Aras G; Kricorian G; Gelfand JM
    J Am Acad Dermatol; 2013 May; 68(5):756-64. PubMed ID: 23357569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: efficacy, safety and impact on patients' quality of life.
    De Felice C; Mazzotta A; Esposito M; Bianchi L; Chimenti S
    J Dermatolog Treat; 2006; 17(6):355-8. PubMed ID: 17853309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B virus-related membranous nephropathy treated with entecavir.
    Ikee R; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Ohtake T; Kobayashi S
    Nephrology (Carlton); 2010 Mar; 15(2):266. PubMed ID: 20470290
    [No Abstract]   [Full Text] [Related]  

  • 57. Etanercept therapy for psoriasis in a patient with concomitant hepatitis C and liver transplant.
    Collazo MH; González JR; Torres EA
    P R Health Sci J; 2008 Dec; 27(4):346-7. PubMed ID: 19069362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Etanercept: efficacy and safety.
    Jiménez-Puya R; Gómez-García F; Amorrich-Campos V; Moreno-Giménez JC
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):402-5. PubMed ID: 19210697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy.
    Gordon KB; Gottlieb AB; Leonardi CL; Elewski BE; Wang A; Jahreis A; Zitnik R
    J Dermatolog Treat; 2006; 17(1):9-17. PubMed ID: 16467018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study.
    Daudén E; Griffiths CE; Ortonne JP; Kragballe K; Molta CT; Robertson D; Pedersen R; Estojak J; Boggs R
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1374-82. PubMed ID: 19563497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.